Back to Search
ANDREA KING, PH.D.
PH.D.
Psychiatry Physician
NPI: 1689793382IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
CMS Specialties
PrimaryCLINICAL PSYCHOLOGIST
Education
OTHER
Class of 1992
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Differences in the effectiveness of individual-level smoking cessation interventions by socioeconomic status.
PMID 39868569·Cochrane Database Syst Rev·2025
1-meta
Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily: A Randomized Clinical Trial.
PMID 35244704·JAMA Netw Open·2022
2-rct
Interventions for preventing weight gain after smoking cessation.
PMID 34611902·Cochrane Database Syst Rev·2021
1-meta
Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
PMID 25005652·JAMA·2014
4-observational
Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence.
PMID 20306175·Psychopharmacology (Berl)·2010
4-observational
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
PMID 16820547·JAMA·2006
4-observational
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
PMID 15887955·J Med Chem·2005
7-preclinical
Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization.
PMID 15528443·Science·2004
7-preclinical
Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study.
PMID 19302083·Alcohol Clin Exp Res·2009
2-rct
A pilot community-based intensive smoking cessation intervention in African Americans: feasibility, acceptability and early outcome indicators.
PMID 18300538·J Natl Med Assoc·2008
8-other
Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences.
PMID 17008194·Nicotine Tob Res·2006
2-rct
Attenuated cortisol response to alcohol in heavy social drinkers.
PMID 16359745·Int J Psychophysiol·2006
4-observational
Alcohol dose-dependent increases in smoking urge in light smokers.
PMID 15834219·Alcohol Clin Exp Res·2005
3-trial
Alcohol-induced performance impairment in heavy episodic and light social drinkers.
PMID 15000501·J Stud Alcohol·2004
3-trial
Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy.
PMID 15063912·J Subst Abuse Treat·2004
8-other
Role of naltrexone in initial smoking cessation: preliminary findings.
PMID 12500129·Alcohol Clin Exp Res·2002
3-trial
Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism.
PMID 12007748·Neuropsychopharmacology·2002
4-observational
Biphasic alcohol response differs in heavy versus light drinkers.
PMID 12068251·Alcohol Clin Exp Res·2002
3-trial
Naltrexone alteration of acute smoking response in nicotine-dependent subjects.
PMID 10899371·Pharmacol Biochem Behav·2000
3-trial
Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamster.
PMID 19478132·J Pharmacol Exp Ther·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5841 S MARYLAND AVE, MC 3077
CHICAGO, IL 60637 - Phone
- (773) 702-6751
Quick Facts
- NPI
- 1689793382
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile